SurModics (SRDX) Tops Q4 EPS by 22c

SurModics (NASDAQ: SRDX) reported Q4 EPS of ($0.26), $0.22 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $25.99 million versus the consensus estimate of $24.09 million.

For earnings history and earnings-related data on SurModics (SRDX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• ICICI Securities Starts Cemindia Projects (CEMPRO:IN) at Buy (1)
• Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'